EDGAR Filing Documents for 0001178913-21-002924

Form PRE 14A - Other preliminary proxy statements:

SEC Accession No. 0001178913-21-002924

Filing Date

2021-09-03

Accepted

2021-09-03 16:04:17

Documents

Period of Report

2021-09-03

Document Format Files

Seq	Description	Document	Type	Size
1	PRE 14A	zk2126532.htm	PRE 14A	284773
2		image9.jpg	GRAPHIC	64788
3		image10.jpg	GRAPHIC	66850
4		sc2.jpg	GRAPHIC	2276
5		sc3.jpg	GRAPHIC	1742
6		sc4.jpg	GRAPHIC	5537
7		sc.jpg	GRAPHIC	4665
	Complete submission text file	0001178913-21-002924.txt		487252

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002

Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156

Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38807 | Film No.: 211236461
SIC: 2834 Pharmaceutical Preparations